Consultation on “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations)

Consultation on “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations) Consultation on guidance document: Drugs for Clinical Trials Involving Human Subjects. 2022-06-07 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyconsultationguidance documentdrugs for clinical-trialsdrugs involving human-subjects Consultation on “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations)HTML https://www.canada.ca/en/health-canada/programs/consultation-drugs-clinical-trials-involving-human-subjects.html Consultation on “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations)HTML https://www.canada.ca/fr/sante-canada/programmes/consultation-drogues-destinees-essais-cliniques-sujets-humains.html

Consultation on guidance document: Drugs for Clinical Trials Involving Human Subjects.

Data and Resources

Similar records